Related Experiment Video
Updated: Aug 13, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Cancer and male factor infertility
1Department of Surgery, Walter Reed Army Medical Center, Washington, DC, USA.
Abstract:
With the increasing success of multimodality anticancer therapy, most men of reproductive age will survive their malignancy. Reproductive function is a principal concern of these men. Health-care providers are shifting the focus of oncologic care toward improving the quality of life in cancer patients, particularly with regard to fertility. For unknown reasons, fertility and sexual function are adversely affected in men with germ cell tumors and Hodgkin's disease prior to the initiation of therapy. Despite these pretreatment abnormalities, fertility potential remains good. Cancer therapy utilizing physical and chemical treatment methods can temporarily or permanently damage spermatogonia, resulting in azoospermia and infertility. Recovery of spermatogenesis can take up to 10 years after therapy. Alternative treatment regimens can preserve reproductive function while maintaining high therapeutic efficacy. Surgical treatment should be directed toward maintaining the neurovascular mechanisms responsible for seminal emission and ejaculation. With new developments in assisted reproductive techniques, even cancer patients with severe oligoasthenospermia can father children. These techniques have not been found to increase the incidence of major or minor birth defects.
Insights
Cancer survivors can preserve fertility. Treatments may impact sperm production, but recovery is possible, and assisted reproductive technologies offer options for fatherhood.
Area of Science:
- Oncology
- Reproductive Medicine
- Men's Health
Background:
- Multimodality anticancer therapies improve survival rates for men of reproductive age.
- Fertility and sexual function concerns are paramount for cancer survivors.
- Pretreatment fertility abnormalities are observed in men with germ cell tumors and Hodgkin's disease.
Purpose of the Study:
- To review the impact of cancer therapy on male reproductive function.
- To discuss strategies for preserving fertility during cancer treatment.
- To highlight advancements in assisted reproductive techniques for cancer patients.
Main Methods:
- Review of current literature on cancer therapy and male fertility.
- Analysis of treatment modalities affecting spermatogenesis.
- Evaluation of fertility preservation and assisted reproductive techniques.
Main Results:
- Cancer therapies can cause temporary or permanent damage to spermatogonia, leading to infertility.
- Spermatogenesis recovery may take up to 10 years post-therapy.
- Surgical techniques can preserve neurovascular mechanisms for ejaculation.
- Assisted reproductive technologies enable fatherhood even in cases of severe oligoasthenospermia without increasing birth defect rates.
Conclusions:
- Fertility preservation is a key aspect of survivorship care in oncology.
- Alternative treatment regimens and surgical approaches can maintain reproductive function.
- Assisted reproductive technologies provide viable options for cancer patients seeking to father children.
Related Concept Videos
Spermatogenesis
Cancer Prevention
Some...
Cancer Prevention
Some...
Infertility in Males
Infertility in Females
Endometriosis, a condition characterized by abnormal growth of endometrial...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

